QINZAVRA Trademark

Trademark Overview

On Thursday, June 23, 2022, a trademark application was filed for QINZAVRA with the United States Patent and Trademark Office. The USPTO has given the QINZAVRA trademark a serial number of 97471776. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by Merck Sharp & Dohme LLC. The QINZAVRA trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine preparations
qinzavra

General Information

Serial Number97471776
Word MarkQINZAVRA
Filing DateThursday, June 23, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

Goods and ServicesHuman vaccine preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events

Event DateEvent Description
Monday, June 27, 2022NEW APPLICATION ENTERED
Wednesday, June 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 21, 2023ASSIGNED TO EXAMINER
Wednesday, March 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 8, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 8, 2023SOU EXTENSION 1 FILED
Friday, March 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

qinzavra preparations vaccine human